RIDGEVIEW INSTITUTE MONROE — History
CCN 114037 | 3-year financial timeline | COVID resilience: 86/100
🛡️ Public data only — no PHI permitted on this instance.
$23M
Latest Revenue (FY2022)
+11.2%
Revenue CAGR (3yr)
7.3%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $19M | $21M | $23M | +11.5% | +11.2% |
| Operating Expenses | $18M | $20M | $22M | +10.8% | +10.0% |
| Operating Margin | 5.2% | 6.7% | 7.3% | +8.9% | +18.6% |
| Net Income | $1M | $1M | $2M | +21.4% | +32.0% |
| Licensed Beds | 88 | 88 | 111 | +26.1% | +12.3% |
| Total Patient Days | 26,235 | 28,897 | 31,969 | +10.6% | +10.4% |
| Medicare Day % | 6% | 5% | 4% | -17.4% | -20.8% |
| Medicaid Day % | 0% | 0% | 0% | +103.0% | +28.1% |
COVID Impact & Recovery
Resilience Score: 86/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +23.7% ($19M → $23M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▲ Growing
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+11.2%
This Hospital
+7.6%
State Avg
Latest Margin
7.3%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $26M | 8.4% |
| FY2024 (proj) | $28M | 9.5% |
| FY2025 (proj) | $30M | 10.5% |